Skyworks Solutions Inc
Change company Symbol lookup
Select an option...
SWKS Skyworks Solutions Inc
AOS A O Smith Corp
TZPS TZP Strategies Acquisition Corp
RCI Rogers Communications Inc
BZUN Baozun Inc
TCNNF Trulieve Cannabis Corp
ENVA Enova International Inc
ZBRA Zebra Technologies Corp
GD General Dynamics Corp
PSA-L Public Storage
Go

Information Technology : Semiconductors & Semiconductor Equipment | Mid Cap Value
Company profile

Skyworks Solutions, Inc. is engaged in designing, manufacturing, and marketing, semiconductor products, including intellectual property. The Company’s analog semiconductors are connecting people, places, and things, across new applications within the aerospace, automotive, broadband, cellular infrastructure, connected home, entertainment, and gaming, industrial, medical, military, smartphone, tablet, and wearable markets. It operates engineering, manufacturing, sales, and service facilities throughout Asia, Europe, and North America. Its system solutions include Sky5, diversity receive (DRx) and multi-input multi-output (MIMO), SkyOne, antenna management, and integrated infrastructure. It offers a range of products, such as Amplifiers, Antenna Tuners, Attenuators, Automotive Tuners and Digital Radios, Circulators/Isolators, Demodulators, Detectors, Digital Power Isolators, Diodes, Directional Couplers, Diversity Receive Modules, Filters, Mixers, Modulators, Receivers, and Switches.

Closing Price
$113.41
Day's Change
3.16 (2.87%)
Bid
--
Ask
--
B/A Size
--
Day's High
113.97
Day's Low
110.99
Volume
(Light)
Volume:
1,520,722

10-day average volume:
2,004,971
1,520,722

APYX, APPS & VRCA Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm, Reminds Investors to Contact the Firm and Actively Participate

11:02 am ET June 29, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / June 29, 2022 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Apyx Medical Corporation (NASDAQ:APYX)

Class Period: May 12, 2021 - March 11, 2022

Deadline: August 5, 2022

For more info: www.bgandg.com/apyx

That Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) consequently, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Digital Turbine, Inc.(NASDAQ:APPS)

Class Period: August 9, 2021 - May 17, 2022

Deadline: August 5, 2022

For more info: www.bgandg.com/apps1

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading, and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company's recent acquisitions, AdColony and Fyber, act as agents in certain of their respective product lines; (2) that, as a result, revenues for those product lines must be reported net of license fees and revenue share, rather than on a gross basis; (3) that the Company's internal control over financial reporting as to revenue recognition was deficient; and (4) that, as a result of the foregoing, the Company's net revenues was overstated throughout fiscal 2022; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Verrica Pharmaceuticals Inc.(NASDAQ:VRCA)

Class Period: May 28, 2021 - May 24, 2022

Deadline: August 5, 2022

For more info: www.bgandg.com/vrca

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading, and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there were manufacturing deficiencies at the facility where the Company's contract manufacturer produced bulk solution for VP-102; (2) that these deficiencies were not remediated when the Company resubmitted its NDA for VP-12 for molluscum; (3) that the foregoing presented significant risks to the Company obtaining regulatory approval of VP-102 for molluscum; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Nathanson

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC





View source version on accesswire.com:

https://www.accesswire.com/704565/APYX-APPS-VRCA-Class-Actions-Bronstein-Gewirtz-Grossman-LLC-A-Top-Class-Action-Firm-Reminds-Investors-to-Contact-the-Firm-and-Actively-Participate



comtex tracking

COMTEX_409427124/2457/2022-06-29T11:02:22

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.